Literature DB >> 26798556

Descriptive epidemiology of infectious gastrointestinal illnesses in Sydney, Australia, 2007-2010.

Stephanie Fletcher1, David Sibbritt2, Damien Stark3, John Harkness3, William Rawlinson4, David Andresen5, Sebastian Van Hal6, Juan Merif7, John Ellis8.   

Abstract

OBJECTIVE: There is a lack of information about the prevalence of gastrointestinal illnesses in Australia. Current disease surveillance systems capture only a few pathogens. The aim of this study is to describe the epidemiology of infectious gastrointestinal illnesses in Sydney, Australia.
METHODS: A retrospective cross-sectional study of patients with gastrointestinal symptoms who visited tertiary public hospitals in Sydney was conducted between 2007 and 2010. Patients with diarrhoea or loose stools with an enteric pathogen detected were identified. Demographic, clinical and potential risk factor data were collected from their medical records. Measures of association, descriptive and inferential statistics were analysed.
RESULTS: In total, 1722 patients were included in this study. Campylobacter (22.0%) and Clostridium difficile (19.2%) were the most frequently detected pathogens. Stratified analysis showed that rotavirus (22.4%), norovirus (20.7%) and adenovirus (18.1%) mainly affected children under 5 years; older children (5-12 years) were frequently infected with Campylobacter spp. (29.8%) and non-typhoid Salmonella spp. (24.4%); infections with C. difficile increased with age.Campylobacter and non-typhoid Salmonella spp. showed increased incidence in summer months (December to February), while rotavirus infections peaked in the cooler months (June to November). DISCUSSION: This study revealed that gastrointestinal illness remains a major public health issue in Sydney. Improvement of current disease surveillance and prevention and control measures are required. This study emphasizes the importance of laboratory diagnosis of enteric infections and the need for better clinical data collection to improve management of disease risk factors in the community.

Entities:  

Mesh:

Year:  2015        PMID: 26798556      PMCID: PMC4712528          DOI: 10.5365/WPSAR.2015.6.2.006

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN: 2094-7321


  31 in total

1.  Sexual risk behaviour increases and is associted with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000.

Authors:  P Van de Ven; G Prestage; J Crawford; A Grulich; S Kippax
Journal:  AIDS       Date:  2000-12-22       Impact factor: 4.177

Review 2.  Ineffective humoral immunity in the elderly.

Authors:  Kiley S McGlauchlen; Laura A Vogel
Journal:  Microbes Infect       Date:  2003-11       Impact factor: 2.700

3.  Communicable enteric disease surveillance, New South Wales, 2000-2002.

Authors:  Leonie Neville; Jeremy McAnulty
Journal:  N S W Public Health Bull       Date:  2004 Jan-Feb

4.  Locally acquired infection with Entamoeba histolytica in men who have sex with men in Australia.

Authors:  Damien J Stark; Rashmi Fotedar; John T Ellis; John L Harkness
Journal:  Med J Aust       Date:  2006-10-16       Impact factor: 7.738

5.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Factors associated with seeking medical care and submitting a stool sample in estimating the burden of foodborne illness.

Authors:  Elaine Scallan; Timothy F Jones; Alicia Cronquist; Stepy Thomas; Paul Frenzen; Dina Hoefer; Carlota Medus; Fredrick J Angulo
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

Review 7.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 8.  Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.

Authors:  D Stark; S van Hal; D Marriott; J Ellis; J Harkness
Journal:  Int J Parasitol       Date:  2006-10-12       Impact factor: 3.981

9.  Investigating an outbreak of staphylococcal food poisoning among travellers across two Australian states.

Authors:  Stephanie Fletcher; Leng Boonwaat; Terry Moore; Ruchir Chavada; Stephen Conaty
Journal:  Western Pac Surveill Response J       Date:  2015-05-04

10.  Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia.

Authors:  Gillian Hall; Keflemariam Yohannes; Jane Raupach; Niels Becker; Martyn Kirk
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

View more
  4 in total

1.  A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older Australians.

Authors:  Y Chen; K Glass; B Liu; T V Riley; R Korda; M D Kirk
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

2.  Trends in rotavirus from 2001 to 2015 in two paediatric hospitals in Atlanta, Georgia.

Authors:  B K Sederdahl; J Yi; R C Jerris; S E Gillespie; L F Westblade; C S Kraft; A L Shane; E J Anderson
Journal:  Epidemiol Infect       Date:  2018-02-12       Impact factor: 4.434

3.  Comparison of two different combined test strips with fluorescent microspheres or colored microspheres as tracers for rotavirus and adenovirus detection.

Authors:  Na Jiang; Lei Shi; Jieping Lin; Lifang Zhang; Yanxia Peng; Huiying Sheng; Ping Wu; Qingjun Pan
Journal:  Virol J       Date:  2018-03-13       Impact factor: 4.099

4.  Prevalence, associated risk factors and antimicrobial susceptibility patterns of Shigella infections among diarrheic pediatric population attending at Gondar town healthcare institutions, Northwest Ethiopia.

Authors:  Amare Alemu; Mekuanint Geta; Selomon Taye; Setegn Eshetie; Tigist Engda
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.